NASDAQ:PRQR - ProQR Therapeutics N.V.
$14.76
 $-0.24
-1.60%
4:00PM EDT
2019-03-25
ProQR Therapeutics N.V. (ProQR), formerly ProQR Therapeutics B.V., is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide, for the treatment of Lebers congenital amaurosis (LCA), and QR-313 for the treatment of dystrophic epidermolysis bullosa (DEB). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  PRQR     avg for
industry  
  avg for
sector  
42 stocks weight:  54. 30   0. 00   0. 00  
42 stocks rank:  1. 53 K 1. 47 K 813. 28  
# analyst opinions:  8. 00   14. 60   13. 76  
mean recommendation:  1. 80   2. 08   1. 94  

quick ratio:  13. 09   5. 02   1. 92  
current ratio:  13. 28   5. 37   2. 41  

target price low:  20. 00   86. 57   112. 35  
target price avg:  29. 50   113. 88   131. 59  
target price high:  40. 00   139. 18   151. 05  
1-yr high:  22. 40   117. 54   131. 86  
last close:  14. 76   98. 55   115. 48  
50-day avg:  14. 68   99. 18   115. 72  
200-day avg:  13. 99   97. 41   113. 92  
1-yr low:  2. 95   75. 41   92. 07  
volume:  238. 37 K 2. 47 M 4. 15 M
50-day avg volume:  157. 29 K 2. 85 M 4. 53 M
200-day avg volume:  300. 87 K 2. 93 M 4. 35 M

1-day return:  -1. 60 % 0. 22 % -0. 06 %
this week return:  -1. 60 % 0. 22 % -0. 06 %
12-wk return:  -20. 13 % 10. 73 % 9. 15 %
52-wk return:  362. 46 % 9. 95 % 19. 39 %

enterprise value (EV):  583. 31 M 51. 84 B 103. 78 B
market cap:  571. 44 M 45. 80 B 92. 73 B
debt/equity:  10. 13   38. 58   85. 69  

shares outstanding:  38. 72 M 579. 54 M 1. 21 B
shares:  23. 17 M 579. 89 M 1. 18 B
shares short:  2. 42 M 9. 60 M 17. 98 M
shares short prior month:  2. 35 M 10. 48 M 11. 44 M
short ratio:  8. 54   5. 48   3. 47  

book value:  3. 09   13. 42   27. 58  
price/book:  4. 78   2. 67   -3. 06  
gross profits:  5. 76 M 8. 18 B 37. 21 B
operating margins:  0. 00 % -691. 69 % -99. 65 %
EBITDA margins:  0. 00 % 12. 76 % 20. 68 %
profit margins:  0. 00 % 9. 80 % 9. 36 %
gross margins:  100. 00 % 42. 57 % 53. 92 %

1-yr max volatility:  120. 75 % --- ---
1-yr mean volatility:  0. 89 % 0. 05 % 0. 08 %

1-yr EPS:  -1. 31   2. 98   3. 81  
forward EPS:  -2. 09   4. 58   6. 86  
P/E:  -11. 28   17. 33   25. 71  
forward P/E:  -7. 18   -44. 22   11. 00  
PE/G:  2. 24   -2. 22   0. 51  
growth:  -5. 04 % 94. 22 % 28. 45 %
earnings high:  -0. 32   1. 15   1. 57  
earnings avg:  -0. 42   0. 90   1. 44  
earnings low:  -0. 59   0. 61   1. 32  
revenue high:  1. 57 M 2. 74 B 10. 73 B
revenue avg:  810. 00 K 2. 65 B 10. 55 B
revenue low:  -0. 00   2. 54 B 10. 35 B
return on assets:  -27. 77 % -1. 39 % 5. 03 %
return on equity:  -56. 19 % -7. 64 % 6. 55 %

beta (1yr vs S&P500):  0. 70   1. 25   0. 95  
sharpe (1yr):  1. 62   0. 55   1. 18  

held % insiders:  20. 63 % 6. 44 % 3. 73 %
held % institutions:  82. 75 % 79. 27 % 68. 99 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-03-25 : PRQR
.    + 2.534 =         2.534 :: INITIAL WEIGHT
.   + 47.891 =        50.425 :: inverse volume-to-price addition
.   + 39.439 =        89.864 :: spline projection addition
.   - 21.227 =        68.637 :: add/subtract for performance
.    x 4.952 =       339.896 :: 13 weeks' performance factor
.     x 4.92 =      1672.287 :: one-year gains+dividend factor
.    x 1.437 =       2403.12 :: industry recommendation factor
.    x 2.515 =      6044.436 :: symbol recommendation factor
.    x 0.997 =      6027.648 :: return on assets factor
.    x 0.994 =       5993.78 :: return on equity factor
.    x 2.472 =     14817.211 :: current ratio factor
.    x 1.041 =     15417.777 :: quick ratio factor
.    x 1.057 =     16295.475 :: short ratio factor
.    x 2.048 =     33370.092 :: price-to-book factor
.    x 1.124 =     37495.145 :: debt-to-equity factor
.     x 1.07 =     40124.799 :: 5-day avg > 200-day avg
.     x 1.02 =     40909.309 :: 5-day avg > 50-day avg
.     x 1.05 =      42938.88 :: 50-day avg > 200-day avg
.    x 1.893 =     81304.709 :: P/E weight
.    x 0.817 =     66455.114 :: PE/G factor
.    x 1.696 =     112680.04 :: beta factor
.    x 1.619 =    182463.005 :: sharpe factor
.    x 1.629 =     297244.39 :: target low factor
.    x 1.333 =    396258.702 :: target mean factor
.    x 1.131 =    448076.662 :: target high factor
.    x 1.107 =    496160.239 :: industry 12-weeks return
.      x 1.0 =    495945.056 :: overall "drift" factor
.    x 0.782 =    387763.658 :: largest single-day jump factor
.    x 0.413 =    160232.916 :: low price factor
.    x 0.999 =    160126.165 :: factor hist industry gain for week 12
.   cubeRoot =        54.303 :: reduced to standardize
.                     54.303 :: FINAL WEIGHT for NASDAQ:PRQR


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org